Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-30 11:06 am Purchase |
2024-01-24 | 13G | Spruce Biosciences, Inc. SPRB |
Rosalind Advisors, Inc. | 2,322,000 5.670% |
2,322,000 (New Position) |
Filing History |
| 2023-11-28 4:53 pm Sale |
2023-11-17 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 2,410,524 9.900% |
-102,227 (-4.07%) |
Filing History |
| 2023-08-28 1:46 pm Purchase |
2023-08-25 | 13G | Myomo, Inc. MYO |
Rosalind Advisors, Inc. | 7,333,334 9.800% |
6,780,044 (+1225.41%) |
Filing History |
| 2023-07-27 6:09 pm Purchase |
2023-07-11 | 13G | OptiNose, Inc. OPTN |
Rosalind Advisors, Inc. | 429,000 5.800% |
429,000 (New Position) |
Filing History |
| 2023-06-07 5:33 pm Purchase |
2023-06-01 | 13G | InspireMD, Inc. NSPR |
Rosalind Advisors, Inc. | 8,988,318 9.900% |
8,988,318 (New Position) |
Filing History |
| 2023-02-15 3:19 pm Purchase |
2022-12-31 | 13G | SIENTRA INC SIENQ |
Rosalind Advisors, Inc. | 509,274 5.000% |
509,274 (New Position) |
Filing History |
| 2023-02-15 1:16 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 2,499,993 4.200% |
314,329 (+14.38%) |
Filing History |
| 2023-02-13 5:53 pm Unchanged |
2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 2,158,272 9.970% |
0 (Unchanged) |
Filing History |
| 2022-12-21 12:37 pm Purchase |
2022-12-02 | 13G | MediWound Ltd. MDWD |
Rosalind Advisors, Inc. | 444,326 6.100% |
444,326 (New Position) |
Filing History |
| 2022-12-21 12:17 pm Purchase |
2022-12-13 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 2,512,751 9.900% |
692,042 (+38.01%) |
Filing History |
| 2022-11-02 8:03 pm Purchase |
2022-10-25 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 2,158,272 9.970% |
1,553,044 (+256.60%) |
Filing History |
| 2022-07-21 3:52 pm Purchase |
2022-07-18 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 1,820,709 9.900% |
566,751 (+45.20%) |
Filing History |
| 2022-07-06 4:34 pm Purchase |
2022-06-22 | 13G | Guided Therapeutics, Inc. GTHP |
Rosalind Advisors, Inc. | 2,338,740 8.300% |
2,338,740 (New Position) |
Filing History |
| 2022-03-09 5:09 pm Purchase |
2022-02-28 | 13G | Trevi Therapeutics, Inc. TRVI |
Rosalind Advisors, Inc. | 2,185,664 8.500% |
2,185,664 (New Position) |
Filing History |
| 2022-03-09 4:45 pm Unchanged |
2021-12-31 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 1,253,958 9.900% |
0 (Unchanged) |
Filing History |
| 2022-02-14 5:09 pm Unchanged |
2021-12-31 | 13D | Delcath Systems, Inc. DCTH |
Rosalind Advisors, Inc. | 1,253,958 9.900% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:12 pm Sale |
2021-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
Rosalind Advisors, Inc. | 707,467 1.500% |
-1,900,390 (-72.87%) |
Filing History |
| 2022-02-14 3:15 pm Sale |
2021-12-31 | 13G | PLX PHARMA INC PLXPQ |
Rosalind Advisors, Inc. | 0 0.000% |
-970,425 (Position Closed) |
Filing History |
| 2022-02-11 5:14 pm Purchase |
2022-02-04 | 13G | Galera Therapeutics, Inc. GRTX |
Rosalind Advisors, Inc. | 1,543,783 5.800% |
1,543,783 (New Position) |
Filing History |
| 2022-01-21 3:49 pm Purchase |
2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Rosalind Advisors, Inc. | 605,228 9.970% |
284,512 (+88.71%) |
Filing History |